참고문헌
- Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983;8:763-775. https://doi.org/10.1016/S0190-9622(83)80003-6
- Scully C, Bagan J. Oral mucosal diseases: erythema multiforme. Br J Oral Maxillofac Surg 2008;46:90-95. https://doi.org/10.1016/j.bjoms.2007.07.202
- Bean SF, Quezada RK. Recurrent oral erythema multiforme. Clinical experience with 11 patients. JAMA 1983;249:2810-2812. https://doi.org/10.1001/jama.1983.03330440048031
- Lozada-Nur F, Gorsky M, Silverman S Jr. Oral erythema multiforme: clinical observations and treatment of 95 patients. Oral Surg Oral Med Oral Pathol 1989;67:36-40. https://doi.org/10.1016/0030-4220(89)90299-5
- Cote B, Wechsler J, Bastuji-Garin S, Assier H, Revuz J, Roujeau JC. Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol 1995;131:1268-1272. https://doi.org/10.1001/archderm.1995.01690230046008
- Farthing P, Bagan JV, Scully C. Mucosal disease series. Number IV. Erythema multiforme. Oral Dis 2005;11:261-267. https://doi.org/10.1111/j.1601-0825.2005.01141.x
- French LE, Prins C. Erythema multiforme, Stevens-Johnson Syndrome and toxic epidermal necrolysis. In: Bolognia JL, Jorizzo JL, Rapini RP, et al, eds. Dermatology. 2nd ed. London: Mosby Elsevier; 2008. pp. 287-300.
- Samim F, Auluck A, Zed C, Williams PM. Erythema multiforme: a review of epidemiology, pathogenesis, clinical features, and treatment. Dent Clin North Am 2013;57:583-596. https://doi.org/10.1016/j.cden.2013.07.001
- Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J 2003;9:1.
- Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet 2000;356:1587-1591. https://doi.org/10.1016/S0140-6736(00)03137-8
- Paul C, Wolkenstein P, Adle H, et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996;134:710-714. https://doi.org/10.1111/j.1365-2133.1996.tb06976.x
- Meyboom RH, Hekster YA, Egberts AC, Gribnau FW, Edwards IR. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997;17:374-389. https://doi.org/10.2165/00002018-199717060-00004
- Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255-1259. https://doi.org/10.1016/S0140-6736(00)02799-9
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245. https://doi.org/10.1038/clpt.1981.154
- Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA 1979;242:623-632. https://doi.org/10.1001/jama.1979.03300070019017
- Son MK, Lee YW, Jung HY, et al. Comparison of the naranjo and WHO-uppsala monitoring centre criteria for causality assessment of adverse drug reactions. Korean J Med. 2008;74:181-7.
- Fischer TW, Bauer HI, Graefe T, Barta U, Elsner P. Erythema multiforme-like drug eruption with oral involvement after intake of leflunomide. Dermatology 2003;207:386-389. https://doi.org/10.1159/000074120
- Omoregie FO, Ukpebor M, Saheeb BD. Methotrexate-induced erythema multiforme: a case report and review of the literature. West Afr J Med 2011;30:377-379.